Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4828 | 1718 | 43.2 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
51 | 3 | HEMATOLOGY//BONE MARROW TRANSPLANTATION//BLOOD | 91443 |
56 | 2 | MYELODYSPLASTIC SYNDROME//HEMATOLOGY//ACUTE MYELOID LEUKEMIA | 29625 |
4828 | 1 | RUNX3//AML1 ETO//RUNX1 | 1718 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RUNX3 | authKW | 1346360 | 8% | 57% | 134 |
2 | AML1 ETO | authKW | 916481 | 4% | 68% | 76 |
3 | RUNX1 | authKW | 894285 | 7% | 43% | 117 |
4 | AML1 | authKW | 696603 | 4% | 56% | 70 |
5 | RUNX | authKW | 539586 | 3% | 53% | 57 |
6 | T821 | authKW | 360300 | 2% | 48% | 42 |
7 | T8 21 | authKW | 313492 | 1% | 84% | 21 |
8 | INV16 | authKW | 244991 | 2% | 48% | 29 |
9 | CBF BETA MYH11 | authKW | 223301 | 1% | 74% | 17 |
10 | CBF BETA | authKW | 206944 | 1% | 61% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 18314 | 32% | 0% | 544 |
2 | Oncology | 8426 | 37% | 0% | 633 |
3 | Cell Biology | 4021 | 26% | 0% | 443 |
4 | Genetics & Heredity | 3780 | 20% | 0% | 350 |
5 | Biochemistry & Molecular Biology | 1355 | 26% | 0% | 453 |
6 | Developmental Biology | 449 | 4% | 0% | 62 |
7 | Pathology | 68 | 3% | 0% | 43 |
8 | Cell & Tissue Engineering | 49 | 1% | 0% | 10 |
9 | Medicine, Research & Experimental | 34 | 3% | 0% | 50 |
10 | Biophysics | 23 | 3% | 0% | 43 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENESIS DEV SECT | 74139 | 1% | 38% | 11 |
2 | BIOCHEM MOL BIOL F7 26 | 35544 | 0% | 100% | 2 |
3 | ORAL SCI DENTYONSEI BIOTECHNOL | 35544 | 0% | 100% | 2 |
4 | SURG PHYSIOL DIGEST SYSTKAMIGYO KU | 35544 | 0% | 100% | 2 |
5 | VIRAL ONCOL | 30137 | 1% | 7% | 25 |
6 | CELL REGULATSAKYO KU | 26655 | 0% | 50% | 3 |
7 | MOL ASPECTS HEMATOPOIESIS | 25583 | 0% | 24% | 6 |
8 | HEMATOL MALIGNANCY TREATMENT | 23695 | 0% | 67% | 2 |
9 | IL RI EDUC | 23695 | 0% | 67% | 2 |
10 | UVA HLTH SCI | 23695 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER GENETICS AND CYTOGENETICS | 30849 | 6% | 2% | 103 |
2 | LEUKEMIA | 14989 | 5% | 1% | 80 |
3 | BLOOD | 12963 | 9% | 0% | 159 |
4 | ONCOGENE | 8783 | 6% | 1% | 95 |
5 | BLOOD CELLS MOLECULES AND DISEASES | 5730 | 1% | 1% | 24 |
6 | GENES CHROMOSOMES & CANCER | 5696 | 2% | 1% | 32 |
7 | CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | 3698 | 1% | 2% | 10 |
8 | MOLECULAR AND CELLULAR BIOLOGY | 3182 | 4% | 0% | 64 |
9 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 3146 | 2% | 1% | 26 |
10 | LEUKEMIA RESEARCH | 2962 | 2% | 1% | 32 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RUNX3 | 1346360 | 8% | 57% | 134 | Search RUNX3 | Search RUNX3 |
2 | AML1 ETO | 916481 | 4% | 68% | 76 | Search AML1+ETO | Search AML1+ETO |
3 | RUNX1 | 894285 | 7% | 43% | 117 | Search RUNX1 | Search RUNX1 |
4 | AML1 | 696603 | 4% | 56% | 70 | Search AML1 | Search AML1 |
5 | RUNX | 539586 | 3% | 53% | 57 | Search RUNX | Search RUNX |
6 | T821 | 360300 | 2% | 48% | 42 | Search T821 | Search T821 |
7 | T8 21 | 313492 | 1% | 84% | 21 | Search T8+21 | Search T8+21 |
8 | INV16 | 244991 | 2% | 48% | 29 | Search INV16 | Search INV16 |
9 | CBF BETA MYH11 | 223301 | 1% | 74% | 17 | Search CBF+BETA+MYH11 | Search CBF+BETA+MYH11 |
10 | CBF BETA | 206944 | 1% | 61% | 19 | Search CBF+BETA | Search CBF+BETA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LICHT, JD , (2001) AML1 AND THE AML1-ETO FUSION PROTEIN IN THE PATHOGENESIS OF T(8;21) AML.ONCOGENE. VOL. 20. ISSUE 40. P. 5660-5679 | 163 | 80% | 95 |
2 | LAM, K , ZHANG, DE , (2012) RUNX1 AND RUNX1-ETO: ROLES IN HEMATOPOIESIS AND LEUKEMOGENESIS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 17. ISSUE . P. 1120-1139 | 120 | 70% | 43 |
3 | ITO, Y , BAE, SC , CHUANG, LSH , (2015) THE RUNX FAMILY: DEVELOPMENTAL REGULATORS IN CANCER.NATURE REVIEWS CANCER. VOL. 15. ISSUE 2. P. 81 -95 | 97 | 51% | 37 |
4 | DE BRAEKELEER, E , DOUET-GUILBERT, N , MOREL, F , LE BRIS, MJ , FEREC, C , DE BRAEKELEER, M , (2011) RUNX1 TRANSLOCATIONS AND FUSION GENES IN MALIGNANT HEMOPATHIES.FUTURE ONCOLOGY. VOL. 7. ISSUE 1. P. 77-91 | 93 | 74% | 24 |
5 | PETERSON, LF , ZHANG, DE , (2004) THE 8; 21 TRANSLOCATION IN LEUKEMOGENESIS.ONCOGENE. VOL. 23. ISSUE 24. P. 4255-4262 | 88 | 80% | 174 |
6 | MARKOVA, EN , PETROVA, NV , RAZIN, SV , KANTIDZE, OL , (2012) TRANSCRIPTION FACTOR RUNX1.MOLECULAR BIOLOGY. VOL. 46. ISSUE 6. P. 755-767 | 92 | 73% | 0 |
7 | ASOU, N , (2003) THE ROLE OF A RUNT DOMAIN TRANSCRIPTION FACTOR AML1/RUNX1 IN LEUKEMOGENESIS AND ITS CLINICAL IMPLICATIONS.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 45. ISSUE 2. P. 129-150 | 142 | 54% | 35 |
8 | BLYTH, K , CAMERON, ER , NEIL, JC , (2005) THE RUNX GENES: GAIN OR LOSS OF FUNCTION IN CANCER.NATURE REVIEWS CANCER. VOL. 5. ISSUE 5. P. 376-387 | 95 | 53% | 264 |
9 | DOWNING, JR , (1999) THE AML1-ETO CHIMAERIC TRANSCRIPTION FACTOR IN ACUTE MYELOID LEUKAEMIA: BIOLOGY AND CLINICAL SIGNIFICANCE.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 106. ISSUE 2. P. 296-308 | 91 | 72% | 128 |
10 | ICHIKAWA, M , YOSHIMI, A , NAKAGAWA, M , NISHIMOTO, N , WATANABE-OKOCHI, N , KUROKAWA, M , (2013) A ROLE FOR RUNX1 IN HEMATOPOIESIS AND MYELOID LEUKEMIA.INTERNATIONAL JOURNAL OF HEMATOLOGY. VOL. 97. ISSUE 6. P. 726-734 | 58 | 78% | 26 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 7164 | RUNX2//CLEIDOCRANIAL DYSPLASIA//CBFA1 |
2 | 7627 | TEL AML1//TEL//ETV6 |
3 | 16735 | EVI1//EVI 1//RIZ1 |
4 | 552 | ACUTE MYELOID LEUKEMIA//FLT3//FLT3 ITD |
5 | 31489 | TRISOMY 4//ACUTE MYELOID LEUKAEMIA LYMPHOPROLIFERATIVE DISORDERS//B L V |
6 | 5973 | MLL//MLL GENE//11Q23 |
7 | 19585 | PU1//SFPI1 PU1//RADIATION INDUCED AML |
8 | 4109 | HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//HEMATOPOIESIS |
9 | 30554 | GFI1B//GFI1//ZELLBIOL TUMORFOR |
10 | 27965 | PRH//GROUCHO//PROLINE RICH HOMEODOMAIN PRH |